CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases	Hemic and Lymphatic Diseases, hematologic disorder, neoplasm	Recruiting	Phase 1 / Phase 2	2025-08-13		NCT05827835

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Yake Biotechnology Ltd.	30
Zhejiang University	194

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The first affiliated hospital of medical college of zhejiang university	Hangzhou	China	13

Clinical trials